The global Peptide Cancer Vaccine Market is estimated to be valued at US$ 4.44 Billion in 2023 and is expected to exhibit a CAGR of 11.10% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Peptide cancer vaccines are a type of immunotherapy used to treat cancer by targeting tumor-specific antigens. These vaccines stimulate...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian